GRTX.D

Galera Therapeutics, Inc.

Healthcare · Biotechnology

$171.95 sample

+2.81 (+1.66%) 1D

Market cap

$1.04T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-20

Alerts

8

Price$171.95 -13.45% 3M daily closessample

198.66165.72

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20SECDEF 14A filed
Oct 09SEC10-Q filed
Oct 06SEC8-K filed: material event
Oct 01INSInsider buy: Director
Sep 25INSInsider sell: Chief Financial Officer
Sep 21SECForm 144 filed
Sep 16INSInsider buy: Chief Financial Officer
Sep 11INSInsider sell: EVP, Operations

Sign up to see the real GRTX.D record →

Company facts

SEC EDGAR registration

Name: Galera Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +10sample, -100 to +100
Reporting currency: USD

Who is positioning in GRTX.D

sample

Insiders: 27 insider transactions over 90 days, net selling, $446.6M
Congress: 1 members traded over 90 days
Institutions · 13F: 22 funds hold $17.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.2B +11.9% y/y

Q4 2024Q3 2026

Inventory$22.4B +11.8% y/y

Q4 2024Q3 2026

Accounts receivable$15.6B +8.4% y/y

Q4 2024Q3 2026

Total debt$43.3B +8.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $935.0B +12.1% 3M
Sample peer B: $996.8B +8.0% 3M
Sample peer C: $811.6B -1.6% 3M
Sample peer D: $642.3B +6.6% 3M
Sample peer E: $808.8B -9.6% 3M